LV10252A - Panemiens kristaliskas 5-hlor-3-(2-tenoil)-2-oksindolkarboksamida natrija sals iegusanai - Google Patents

Panemiens kristaliskas 5-hlor-3-(2-tenoil)-2-oksindolkarboksamida natrija sals iegusanai

Info

Publication number
LV10252A
LV10252A LV931225A LV931225A LV10252A LV 10252 A LV10252 A LV 10252A LV 931225 A LV931225 A LV 931225A LV 931225 A LV931225 A LV 931225A LV 10252 A LV10252 A LV 10252A
Authority
LV
Latvia
Prior art keywords
oxindolecarboxamide
tenoyl
chloro
saturation
crystalline
Prior art date
Application number
LV931225A
Other languages
English (en)
Other versions
LV10252B (en
Inventor
Douglas John Allen
Brian T O'neil
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer filed Critical Pfizer
Publication of LV10252A publication Critical patent/LV10252A/lv
Publication of LV10252B publication Critical patent/LV10252B/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pain & Pain Management (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Biomedical Technology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Rheumatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Indole Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
LVP-93-1225A 1987-02-02 1993-11-15 Method of preparation of crystallic sodium salt of 5-chloro-3-(2-thenoyl)-2-oxyindolcarboxamide LV10252B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/US1987/000201 WO1988005656A1 (en) 1987-02-02 1987-02-02 Anhydrous, crystalline sodium salt of 5-chloro-3-(2-thenoyl)-2-oxindole-1-carboxamide

Publications (2)

Publication Number Publication Date
LV10252A true LV10252A (lv) 1994-10-20
LV10252B LV10252B (en) 1995-04-20

Family

ID=22202263

Family Applications (1)

Application Number Title Priority Date Filing Date
LVP-93-1225A LV10252B (en) 1987-02-02 1993-11-15 Method of preparation of crystallic sodium salt of 5-chloro-3-(2-thenoyl)-2-oxyindolcarboxamide

Country Status (42)

Country Link
US (1) US5036099A (lv)
EP (1) EP0277738B1 (lv)
JP (1) JPS63201184A (lv)
KR (1) KR900001422B1 (lv)
CN (1) CN1022324C (lv)
AP (1) AP52A (lv)
AR (1) AR243182A1 (lv)
AT (1) ATE73800T1 (lv)
AU (1) AU587736B2 (lv)
BG (1) BG51042A3 (lv)
CA (1) CA1335590C (lv)
CS (2) CS265250B2 (lv)
CY (1) CY1775A (lv)
DD (1) DD267490A5 (lv)
DE (1) DE3869149D1 (lv)
DK (1) DK44888A (lv)
EC (1) ECSP941082A (lv)
ES (1) ES2032955T3 (lv)
FI (1) FI89598C (lv)
GR (1) GR3004200T3 (lv)
HK (1) HK132695A (lv)
IE (1) IE60000B1 (lv)
IL (1) IL85277A (lv)
IN (1) IN171799B (lv)
IS (1) IS1533B (lv)
LV (1) LV10252B (lv)
MA (1) MA21171A1 (lv)
MY (1) MY102737A (lv)
NO (1) NO170581C (lv)
NZ (1) NZ223373A (lv)
OA (1) OA08710A (lv)
PH (1) PH26545A (lv)
PL (1) PL149550B1 (lv)
PT (1) PT86675B (lv)
RO (1) RO105052B1 (lv)
RU (1) RU2011381C1 (lv)
SG (1) SG27994G (lv)
SI (1) SI8810183A8 (lv)
UA (1) UA25898A1 (lv)
WO (1) WO1988005656A1 (lv)
YU (1) YU46766B (lv)
ZA (1) ZA88679B (lv)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4853409A (en) * 1988-04-13 1989-08-01 Pfizer Inc. 3-substituted-2-oxindole-1-carboxamides for suppressing T-cell function
US4861794A (en) * 1988-04-13 1989-08-29 Pfizer Inc. 3-substituted-2-oxindole-1-carboxamides as inhibitors of interleukin-1 biosynthesis
WO1990004393A1 (en) * 1988-10-18 1990-05-03 Pfizer Inc. Prodrugs of antiinflammatory 3-acyl-2-oxindole-1-carboxamides
EP0365194B1 (en) * 1988-10-18 1995-08-02 Pfizer Inc. Prodrugs of antiinflammatory 3-acyl-2-oxindole-1-carboxamides
US5059693A (en) * 1989-10-06 1991-10-22 Pfizer Inc. Process for making 3-aroyl-2-oxindole-1-carboxamides
US5006547A (en) * 1990-03-19 1991-04-09 Pfizer Inc. Tenidap as an inhibitor of the release of elastase by neutrophils
US5008283A (en) * 1990-03-19 1991-04-16 Pfizer Inc. Use of tenidap to inhibit activation of collagenase and to inhibit the activity of myeloperoxidase
US5122534A (en) * 1991-02-08 1992-06-16 Pfizer Inc. Use of tenidap to reduce total serum cholesterol, ldl cholesterol and triglycerides
DE4111305C2 (de) * 1991-04-08 1994-12-01 Mack Chem Pharm Pharmazeutische Zubereitung zur rektalen Applikation, die ein 2-Oxindol-l-carboxamid-derivat enthält
AU7503496A (en) * 1995-12-19 1997-07-14 Pfizer Inc. Stable, long acting salts of indole derivatives for the treatment of joint diseases
EP0826685A1 (en) * 1996-08-21 1998-03-04 Pfizer Inc. Stable, long acting salts of carboxamides for the treatment of joint disease
DE19854355A1 (de) * 1998-11-25 2000-05-31 Bayer Ag Kristallmodifikation B von 8-Cyan-1-cyclopropyl-7-(1S, 6S-2,8-diazabicyclo-/4.3.O/nonan-8-yl)-6-fluor-1,4-dihydro-4-oxo-3-chinolincarbonsäure
US7407195B2 (en) 2004-04-14 2008-08-05 William Berson Label for receiving indicia having variable spectral emissivity values
US7651031B2 (en) * 2004-10-25 2010-01-26 William Berson Systems and methods for reading indicium
US7931413B2 (en) * 2005-01-14 2011-04-26 William Berson Printing system ribbon including print transferable circuitry and elements
US7621451B2 (en) * 2005-01-14 2009-11-24 William Berson Radio frequency identification labels and systems and methods for making the same
US7728726B2 (en) * 2005-01-14 2010-06-01 William Berson Radio frequency identification labels
US7619520B2 (en) * 2005-01-14 2009-11-17 William Berson Radio frequency identification labels and systems and methods for making the same
WO2019087191A1 (en) 2017-11-02 2019-05-09 Accurate Medical Therapeutics Ltd. Embolization catheter with integral filter

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3767653A (en) * 1971-06-28 1973-10-23 Squibb & Sons Inc Thiazines
GB1532413A (en) * 1974-12-23 1978-11-15 Union International Co Ltd Chenodeoxycholic acid
DE2613346C3 (de) * 1976-03-29 1981-07-23 Diamalt AG, 8000 München Monoklin kristalline Chenodesoxycholsäure und Verfahren zu ihrer Herstellung
DE3568776D1 (en) * 1984-02-07 1989-04-20 Pfizer 1,3-disubstituted 2-oxindoles as analgesic and anti-inflammatory agents
US4556672A (en) * 1984-03-19 1985-12-03 Pfizer Inc. 3-Substituted 2-oxindole-1-carboxamides as analgesic and anti-inflammatory agents
DE3579716D1 (de) * 1984-03-19 1990-10-25 Pfizer Verfahren zur herstellung von 2-oxindole-1-carboxamiden und deren zwischenprodukte.
US4569942A (en) * 1984-05-04 1986-02-11 Pfizer Inc. N,3-Disubstituted 2-oxindole-1-carboxamides as analgesic and antiinflammatory agents

Also Published As

Publication number Publication date
YU18388A (en) 1989-10-31
RU2011381C1 (ru) 1994-04-30
IE60000B1 (en) 1994-05-18
SI8810183A8 (sl) 1996-08-31
CA1335590C (en) 1995-05-16
DE3869149D1 (de) 1992-04-23
ATE73800T1 (de) 1992-04-15
UA25898A1 (uk) 1999-02-26
IN171799B (lv) 1993-01-09
PT86675A (pt) 1988-03-01
MA21171A1 (fr) 1988-10-01
MY102737A (en) 1992-09-30
CS64888A2 (en) 1988-08-16
NO884329D0 (no) 1988-09-29
PH26545A (en) 1992-08-19
CN1022324C (zh) 1993-10-06
PL149550B1 (en) 1990-02-28
JPS63201184A (ja) 1988-08-19
LV10252B (en) 1995-04-20
FI893647A0 (fi) 1989-08-01
DK44888D0 (da) 1988-01-29
FI89598C (fi) 1993-10-25
PL270415A1 (en) 1988-12-08
CS354191A3 (en) 1992-04-15
BG51042A3 (en) 1993-01-15
PT86675B (pt) 1992-07-31
CS265250B2 (en) 1989-10-13
NO884329L (no) 1988-09-29
RO105052B1 (en) 1994-12-01
EP0277738A1 (en) 1988-08-10
IS3309A7 (is) 1988-08-03
KR880009961A (ko) 1988-10-06
SG27994G (en) 1994-10-14
AU587736B2 (en) 1989-08-24
DD267490A5 (de) 1989-05-03
IE880269L (en) 1988-08-02
US5036099A (en) 1991-07-30
YU46766B (sh) 1994-05-10
NO170581B (no) 1992-07-27
NZ223373A (en) 1989-06-28
AU1116088A (en) 1988-08-04
KR900001422B1 (ko) 1990-03-09
OA08710A (fr) 1989-03-31
ES2032955T3 (es) 1996-07-16
DK44888A (da) 1988-08-03
WO1988005656A1 (en) 1988-08-11
EP0277738B1 (en) 1992-03-18
CY1775A (en) 1996-04-05
FI89598B (fi) 1993-07-15
AP8800081A0 (en) 1987-11-01
CN88100555A (zh) 1988-08-17
NO170581C (no) 1992-11-04
AR243182A1 (es) 1993-07-30
ZA88679B (en) 1989-09-27
IL85277A (en) 1994-02-27
ECSP941082A (es) 1994-12-15
HK132695A (en) 1995-09-01
GR3004200T3 (lv) 1993-03-31
IL85277A0 (en) 1988-07-31
AP52A (en) 1989-09-16
JPH0576945B2 (lv) 1993-10-25
IS1533B (is) 1994-01-28

Similar Documents

Publication Publication Date Title
LV10252A (lv) Panemiens kristaliskas 5-hlor-3-(2-tenoil)-2-oksindolkarboksamida natrija sals iegusanai
LV5197A3 (lv) Kristaliskas sukralozes iegusanas panemiens
MX12213A (es) Metodo de preparacion de dihidrato de azitromicina cristalino
DK159688A (da) Antimikrobielt praeparat med forsinket frigivelse
DK295288A (da) (1h-azol-1-ylmethyl)substituerede benzotriazolderivater
KR850000458A (ko) 세파로스포린 유도체의 제법
ES533183A0 (es) Amoxicilina sodica cristalina
DK378088A (da) Alkenderivater
DK49688A (da) Propiolophenonderivater
NO172371C (no) For for akvariefisk
DK316589D0 (da) Substituerede azacyclohexylderivater af rifamyciner
IS1422B6 (is) Lína til línuveiða
DK271088A (da) Tienopyridinderivater
DK119588D0 (da) 27-halogen-derivater af ll-f28249-forbindelser
DK382688A (da) Anti-anxiogeniske sammensaetninger indeholdende dioxopiperidin derivater
LV5721B4 (lv) 5-Hlor-3-(2-tenoil-2-oksindola-1-karboksamida bezudens kristaliska natrija sals
PT86621A (pt) Ryfamycin derivative salts
DK608787D0 (da) Benzoquinolinderivater
KR880015566U (ko) 낚 시
BR6700355U (pt) Cabide duplo
CS809187A1 (en) Sodium salt of carboxymethyl-/1-6/-beta-d-gluco-/1-3-beta-d-glucan
LV5243A3 (lv) Pirimidina atvasinajumu iegusanas panemiens
NO874298D0 (no) Fremstilling av stabilt krystallinsk natriumacetylsalisylat.
IT8719447V0 (it) Effetto tunnell
BR6700054U (pt) Peixe borbulhador